1-8 of 8
Mayda Navarrete
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Diagnostic peripheral blood smear for Chédiak-Higashi syndrome in a 43-month-old boy, confirmed by sequencing

Marc Bosch-Schips, Mayda Navarrete
Journal: Blood
Blood (2023) 142 (9): 856.
https://doi.org/10.1182/blood.2023020217
Published: 2023
Journal Articles

Characterization of Terminal Erythroid Differentiation (TED) and Its Prognosis Impact Inpatients with Myelodysplastic Syndrome (MDS)

Marc Bosch Schips, Julia Montoro, Félix López Cadenas, Alba Mesa, Víctor Navarro Garcés, Ana Pérez, Laura Gallur, Silvia Saumell, Mayda Navarrete, Margarita Ortega, Bárbara Tazón, Antonieta Molero, Olga Salamero, Sandra Novoa Jáuregui, Sofia Laura Muzio, Francesc Bosch, David Valcárcel
Journal: Blood
Blood (2022) 140 (Supplement 1): 12308–12310.
https://doi.org/10.1182/blood-2022-157434
Published: 2022
Journal Articles

Acute Myeloid Leukemia with Myelodisplasia-Related Changes (AML-MRC) Defined Only By Morphological Findings May Not Represent a Poor Prognosis AML

Ana Pérez, MD, Olga Salamero, MD, Helena Pomares, MD PhD, Maria Julia Montoro, MD, Montserrat Arnan Sangerman, MD PhD, Laura Gallur, MD, María Laura Fox, MD, Elisa Roldan, MD, Antonieta Molero, MD, Guillermo Ortí, MD, Mayda Navarrete, MD, Esther Alonso, MD, Bárbara Tazón, PhD, M Moraima Jimenez, MD, Margarita Ortega, PhD, Adoración Blanco, PhD, Gael Roue, PhD, Pere Barba, MD PhD, Silvia Saumell, MD PhD, David Valcárcel, MD PhD, Francesc Bosch, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2612.
https://doi.org/10.1182/blood-2019-129153
Published: 2019
Journal Articles

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Jose Tomas Navarro, MD; PhD, Maria Rozman, MD, PhD, Leonor Arenillas, Ana Aventin, Teresa Gimenez, MD, Esther Alonso, MD, PhD, Granada Perea, MD; PhD, Mireia Camós, MD, PhD, Mayda Navarrete, MD, Esperanza Tuset, MD, Lourdes Florensa, MD, Fuensanta Millá, MD, PhD, Josep F Nomdedeu, MD, Esmeralda de la Banda, MD, Marina Díaz-Beyá, MD, Salut Brunet, Jorge Sierra, MD, PhD, Jordi Esteve, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2551.
https://doi.org/10.1182/blood.V120.21.2551.2551
Published: 2012
Journal Articles

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Julia Montoro, MD, Teresa Vallespi, MD, PhD, Esther Sancho, MD, Olga Salamero, MD, Laura Lopez-Andreoni, MD, Carmen sanchez-Morata, MD, Mayda Navarrete, MD, Margarita Ortega, PhD, Sabela Bobillo, MD, Noelia Valdez, MD, Francesc Bosch, MD, PhD, David Valcárcel, MD
Journal: Blood
Blood (2011) 118 (21): 5026.
https://doi.org/10.1182/blood.V118.21.5026.5026
Published: 2011
Journal Articles

Re-Treatment with Rituximab Plus Chemotherapy in Patients with Aggressive Lymphoma Treated Previously with CHOP or CHOP-Like Combinations Plus Rituximab.

Andres Palacios, Mayda Navarrete, Laura Gallur, Javier Zuazu, Cristina Barrenetxea, Eva Sanchez, Andres Lopez
Journal: Blood
Blood (2006) 108 (11): 4707.
https://doi.org/10.1182/blood.V108.11.4707.4707
Published: 2006
Journal Articles

Serum Levels of Soluble Interleukin 10 (IL-10) in Patients with Hodgkin’s Lymphoma: Predictive Value in Advanced Stage.

Mayda Navarrete, MD, Andres Palacios, MD, Maria J. Cruz, BD, Adoracion Blanco, BD, Isabel Caragol, MD,PhD, Andres Lopez, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4590.
https://doi.org/10.1182/blood.V108.11.4590.4590
Published: 2006
Journal Articles

Dose Adjusted EPOCH Chemotherapy Plus Rituximab Combination (DA-R-EPOCH), an Effective Upfront Therapy for Patients with Poor-Risk Aggressive B-Cell Lymphomas. Results of a Pilot Study in a Single Center.

Andrés López, MD, Laura Gallur, MD, Andrés Palacios, MD, Mayda Navarrete, MD, Carmen Ruiz-Marcellán, MD, Josep Castellví, MD, Santiago Ramón y Cajal, MD, Antonio Juliá, MD
Journal: Blood
Blood (2005) 106 (11): 4716.
https://doi.org/10.1182/blood.V106.11.4716.4716
Published: 2005